Multiple myeloma (first line) - bortezomib and thalidomide: commentator comments
Multiple myeloma (first line) - bortezomib and thalidomide: NHS Quality Improvement Scotland
Multiple myeloma (first line) - bortezomib and thalidomide: Clinical Trials Research Unit (CTRU), University of Leeds response
Multiple myeloma (first line) - bortezomib and thalidomide: Southampton Health Technology Assessment Centre, University of Southampton response
This page was last updated: 24 August 2010